Brief: Marker Therapeutics, Mayo Mutually Agree To Terminate Patent & Know-How License Agreement
Oct 20 (Reuters) - Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS-ON OCT 16, CO & MAYO MUTUALLY AGREED
TO
TERMINATE PATENT & KNOW-HOW LICENSE AGREEMENT
* MARKER THERAPEUTICS-ON OCT 16, CO & MAYO MUTUALLY AGREED
TO
TERMINATE LICENSE AND ASSIGNMENT AGREEMENT DATED JULY 21, 2015
* MARKER THERAPEUTICS - UNDER TERMS, THE LICENSE AGREEMENTS
ARE OF
NO FURTHER FORCE OR EFFECT
* MARKER THERAPEUTICS - ALL LICENSE GRANTS UNDER THE LICENSE
AGREEMENTS ARE TERMINATED AND ALL RIGHTS THEREIN REVERT TO MAYO
Further company coverage: MRKR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79